Caspar, Yvan
Deves, A.
Richarme, C.
Le Marechal, M.
Ponderand, L.
Mounayar, A.-L.
Lejeune, S.
Arata-Bardet, J.
Gallouche, M.
Recule, C.
Maubon, D.
Garnaud, C.
Cornet, M.
Veloso, M.
Chabani, B.
Maurin, M.
David-Tchouda, S.
Pavese, P.
Article History
Received: 13 February 2024
Accepted: 21 March 2024
First Online: 27 March 2024
Declarations
:
: All authors have no conflict of interest to declare for this study. Y. Caspar declares study grants from QIAGEN, Becton Dickinson and BAIO-Dx to Grenoble University Hospital and Congress, travel and meeting support from Becton Dickinson France SAS, MENARINI FRANCE and MSD France outside the submitted work. C. Garnaud declares local meeting support from Gilead outside the submitted work. M. Cornet declares consulting fees from Mundipharma and meeting or travel support from Gilead sciences and Pfizer outside the submitted work. M. Maurin declares reaserch grant from Direction Générale de l’Armement to Grenoble Alpes University (ANR ASTRID Tulamibe) and Chief Editor position of Frontiers in Cellular and Infection Microbiology, section Clinical microbiology.